The mystery of how cancers build up resistance mechanisms and evade the treatments that should have destroyed them is a ...

Mantle cell lymphoma treatment offers options if patients relapse after CAR T-cell therapy, from bispecific antibodies, antibody drug conjugates, and other emerging therapies.

During a live event, Matthew Lunning, DO, and participants discussed how identifying primary refractory and early relapsed ...